It appeared, as a peptide native and stable in human gastric juice, as a late outbreak of the cytoprotection/organoprotection concept of Robert and Szabo, a concept mostly from the stomach studies [10,11,12,13,14,15,16,17] for epithelial and endothelial protection, like the previous theoretical/practical breakthroughs in the 1980s and braingut axis and gutbrain axis (for review, see, i.e., [2,3,4,5,6,7,8])
The goal is to surround the knee with BPC-157 so the peptide diffuses inward from multiple directions
Side effects are rare and typically mild, such as slight discomfort at the injection site or temporary bruising
Prevention of vitamin B12 deficiency in people who need more vitamin B12 than usual due to certain conditions (such as pregnancy, thyroid problems, liver or kidney problems)
Obesity 30 , 802840 (2022)